7
Participants
Start Date
December 8, 2021
Primary Completion Date
October 12, 2022
Study Completion Date
October 12, 2022
Ultevursen
RNA antisense oligonucleotide for intravitreal injection
Sham-procedure
Sham-procedure (no experimental drug administered)
Columbia University, New York
Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore
Emory Eye Center, Atlanta
University of Miami, Bascom Palmer Eye Institute, Miami
University of Michigan, Kellogg Eye Center, Ann Arbor
University of Wisconsin - Madison, Madison
Universitaetsklinikum Tuebingen Department für Augenheilkunde, Tübingen
Retina Foundation of the Southwest, Dallas
University of California, San Francisco, San Francisco
Shiley Eye Institute - UC San Diego, San Diego
Center for Clinical Research Operations, Massachusetts Eye and Ear, Boston
RadboudUMC, Nijmegen
Het Oogziekenhuis Rotterdam, Rotterdam
Oxford Eye Hospital, Headington
Moorfields Eye Hospital, London
Lead Sponsor
Sepul Bio
INDUSTRY
Laboratoires Thea
INDUSTRY